Daxor Corporation shares are trading higher after the company was awarded a $1.9 million two-year contract from the U.S. Air Force to develop a point-of-care blood volume analyzer using novel fluorescent tracer and optical sensing technology.
Portfolio Pulse from Benzinga Newsdesk
Daxor Corporation shares are trading higher after being awarded a $1.9 million two-year contract from the U.S. Air Force to develop a point-of-care blood volume analyzer using novel fluorescent tracer and optical sensing technology.
August 06, 2024 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Daxor Corporation shares are trading higher following the announcement of a $1.9 million contract from the U.S. Air Force to develop a point-of-care blood volume analyzer.
The $1.9 million contract from the U.S. Air Force is a significant development for Daxor Corporation, likely boosting investor confidence and driving the stock price higher in the short term. The contract validates the company's technology and provides a new revenue stream.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100